PepsiCo Reportedly Preparing Snack Price Hikes for Late June Britains Energy Shock Editorial Warns MiniMeasures Insufficient Amid Iran Conflict Jim Cramer Urges Focus on Future Upside in AI Stocks Highlights Corning Example Trump Asks Supreme Court to Halt TikTok Ban Sending Ripples Through Tech Sector Russias Renewed Strikes on Kyiv Escalate Geopolitical Tensions Potential Market Implications Anthropic Nears 1 Trillion Valuation After 65 Billion Series H Overtaking OpenAI CING Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Stock Movement GPMT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise EVH Q1 2026 Earnings EPS Surpasses Expectations with 614 Surprise CELC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress but Stock Slips KVYO Q1 2026 Earnings EPS Beat Amidst Modest Stock Decline ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains Algoma Steel Group ASTL Holds Steady at 473 as Traders Eye Key Resistance and Support Levels Red Cat Holdings RCAT Climbs 351 as Drone Sector Sentiment Strengthens Frontdoor Inc FTDR Holds Steady Near Support as Market Watches for Breakout Immunovant IMVT Holds Steady Near Support as Biotech Sector Faces Headwinds Calamos Convertible and High Income Fund CHY Approaches Key Resistance After 189 Gain Spotify Gains Attention as Steve Cohen Portfolio Holding Xtant Medical Holdings Inc XTNT Q1 2026 Earnings EPS Misses Estimates Amidst Narrow Loss PVH Corp PVH Bounces 255 From Support Testing NearTerm Resistance ICFI Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises on Positive Market Sentiment SPS Commerce Q1 2026 Earnings EPS Surprises to the Upside as Operating Discipline Supports Bottom Line Bank of Marin Bancorp BMRC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Landscape EVLV Q1 2026 Earnings Narrow Loss Surprise Lifts Shares NCSM Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Rise SVM Q1 2026 Earnings Strong EPS Beat Highlights Silver and Cost Management Gains BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress